Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer

被引:122
作者
Elias, D.
Benizri, E.
Pocard, M.
Ducreux, M.
Boige, V.
Lasser, P.
机构
[1] Canc Ctr Hosp, Inst Gustave Roussy, Dept Oncol Digest Surg, F-94805 Villejuif, France
[2] Canc Ctr Hosp, Inst Gustave Roussy, Dept Digest Oncol, F-94805 Villejuif, France
来源
EJSO | 2006年 / 32卷 / 06期
关键词
liver metastasis; hepatectomy; peritoneal carcinomatosis; intraperitoneal chemotherapy;
D O I
10.1016/j.ejso.2006.03.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To report our experience of peritoneal carcinomatosis (PC) discovered during abdominal exploration in patients with liver metastases (LM). Methods: Liver resection plus cytoreductive surgery were combined in 24 patients with LM and moderate PC from colorectal origin treated with a curative intent between January 1993 and November 2003. Results: The mean operative time was 357 +/- 112 min and median blood loss was 719 ml. One postoperative death Occurred and postoperative morbidity was 58%. The mean hospital stay was 21.4 +/- 4.2 days. Three-year overall and disease-free survival rates were respectively 41.5% (confidence interval [Cl]: 23-63) and 23.6% (Cl: 11-45). Seven patients are disease-free with a mean follow-up of 27.8 months after their last surgery, 3 having a repeated hepatectomy. Three patients developed a peritoneal recurrence and 13 had recurrence in the liver. The only significant prognostic factor was a number of LMs of less than 3 (p < 0.01). Conclusion: A combined treatment of LM plus PC is feasible and is beneficial in selected patients presenting three or fewer metastases. (C) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:632 / 636
页数:5
相关论文
共 27 条
[1]   The management of synchronous peritoneal carcinomatosis and hematogenous metastasis from colorectal cancer [J].
Carmignani, CP ;
Ortega-Perez, G ;
Sugarbaker, PH .
EJSO, 2004, 30 (04) :391-398
[2]   INTERMITTENT VASCULAR EXCLUSION OF THE LIVER (WITHOUT VENA-CAVA CLAMPING) DURING MAJOR HEPATECTOMY [J].
ELIAS, D ;
LASSER, P ;
DEBAENE, B ;
DOIDY, L ;
BILLARD, V ;
SPENCER, A ;
LECLERCQ, B .
BRITISH JOURNAL OF SURGERY, 1995, 82 (11) :1535-1539
[3]   Regional chemotherapeutic techniques for liver tumors: current knowledge and future directions [J].
Elias, D ;
de Baere, T ;
Sideris, L ;
Ducreux, M .
SURGICAL CLINICS OF NORTH AMERICA, 2004, 84 (02) :607-+
[4]   Efficacy of intraperitoneal chemohyperthermia with oxaliplatin in colorectal peritoneal carcinomatosis.: Preliminary results in 24 patients [J].
Elias, D ;
Sideris, L ;
Pocard, M ;
Edè, C ;
Ben Hassouna, D ;
Ducreux, M ;
Boige, V ;
Côté, JF ;
Lasser, P .
ANNALS OF ONCOLOGY, 2004, 15 (05) :781-785
[5]  
Elias D, 1999, Chirurgie, V124, P380, DOI 10.1016/S0001-4001(00)80010-0
[6]   Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases [J].
Elias, D ;
Ouellet, JF ;
Bellon, N ;
Pignon, JP ;
Pocard, M ;
Lasser, P .
BRITISH JOURNAL OF SURGERY, 2003, 90 (05) :567-574
[7]  
Elias D, 2001, CANCER, V92, P71, DOI 10.1002/1097-0142(20010701)92:1<71::AID-CNCR1293>3.0.CO
[8]  
2-9
[9]  
Elias D, 1997, GASTROEN CLIN BIOL, V21, P181
[10]   Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer - Analysis of 1001 consecutive cases [J].
Fong, Y ;
Fortner, J ;
Sun, RL ;
Brennan, MF ;
Blumgart, LH .
ANNALS OF SURGERY, 1999, 230 (03) :309-318